The lines are blurred here but, in the opinion of the BBA, a good rule of thumb would be the declaration of performance (DoP). If you are making changes that affect this, that would constitute a new product. If these changes are minor formulation changes that do not affect the performance of the product, this may not be substantial enough to be classed as a new product.


<< Back to FAQ’s